In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pepscan Therapeutics

www.pepscantherapeutics.com

Latest From Pepscan Therapeutics

Deals Shaping the Medical Industry (04/2011)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions.

Deals Shaping the Medical Industry (10/2010)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions

Recent Financings of Private Companies (11/2006)

Each month, Start-Up presents a comprehensive review of young, private life science companies that have recieved venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation & reagent sectors.

Recent Dealmaking (06/2003)

Summarizing the month in European dealmaking.
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Pepscan Systems BV
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Benelux
          • Netherlands
  • Parent & Subsidiaries
  • Pepscan Therapeutics
  • Senior Management
  • Wim E. M. Mol, PhD, CEO
    Henk van der Meer, CFO
    Peter van Dijken, PhD, Chief Commerical Officer
    Klaus Schwamborn, PhD, Chief Dev. Officer
    Peter Timmerman, CTO
    Michiel Lodder, CBO
  • Contact Info
  • Pepscan Therapeutics
    Phone: (31) 320 225 300
    Zuidersluisweg 2
    Lelystad, 8243
    Netherlands
Advertisement
Advertisement
UsernamePublicRestriction

Register